Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Chronic Fatigue Syndrome
NCT00848692Phase 3Completed
- Sponsor
- Haukeland University Hospital
- Start
- Jun 2008
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by Haukeland University Hospital. Started Jun 2008; status: completed.
02
Drugs
rituximab
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT00848692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848692.